异常黑胆质型哮喘维吾尔医特色疗法疗效观察

 观察维吾尔医特色疗法治疗异常黑胆质型哮喘患者的疗效。2012 年3 月-2013 年10 月,将新疆医科大学第一附属医院呼吸科门诊及病房内确诊为异常黑胆质型哮喘患者共75 例随机方法分为治疗组(n=38)和对照组(n=37)。治疗组为西医常规治疗基础上加用维吾尔医特色疗法,对照组则为单纯西医常规治疗,两组患者均接受一个疗程(1 个月)治疗。在治疗前与治疗后1 个月观察记录两组患者临床症状、体征,并进行哮喘日夜症状评分、哮喘控制测试(ACT)评分以及成人哮喘患者生存质量(AQLQ)评分。治疗后1 个月,两组患者哮喘症状得以控制者分别为91.9%和94.8%,差异无统计学意义(P>0.05);与治疗前相比,两组患者哮喘日夜症状评分及ACT 评分均有改善,差异有统计学意义(P<0.05),但在治疗后1 个月,两组患者间哮喘日夜症状评分及ACT 评分差异无统计学意义(P>0.05)。与治疗前比较,两组患者治疗后AQLQ 各项评分均有提高(P<0.05)。在治疗后1 个月,治疗组在活动受限、心理状况、对刺激源的反应、对自身健康的关心方面显著高于对照组,差异有统计学意义(P<0.05)。西医联合维吾尔医特色疗法在改善哮喘症状控制、ACT 评分及哮喘日夜症状评分上,与单纯西医治疗无显著差异。但是,西医联合维吾尔医特色疗法治疗异常黑胆质型哮喘在活动受限、心理状况、对刺激源的反应、对自身健康的关心方面的生活质量的提高改善显著,有一定的优势。

Observation of effects of munziq and mushil therapy on asthma patients with abnormal savda syndrome

This study aims to evaluate the effects of Munziq and Mushil therapy on asthma patients with abnormal savda syndrome. During March 2012 to October 2013, 75 asthma patients with abnormal savda syndrome from Rrespiratory Department of the First Affiliated Hospital of Xinjiang Medical University were randomly assigned to the treatment group (n=38) and control group (n=37). The control group received budesonide and formoterol fumarate powder for inhalation (symbicort turbuhaler), and the treatment group received traditional Uyghur medicine combined with those for the control group; The course of treatment was one month. The day and night clinical symptoms of asthma, ACT grade and asthma quality of life questionnaire (AQLQ) grade were observed and compared. In one month, asthma was well controlled in 91.9% of patients in the control group and 94.8% of patients in the treatment group, but the difference was not significant statistically (P>0.05). Compared to the baseline, day and night symptom controlled scores and ACT scores increased in both groups, but not statistically different in one month (P>0.05). The AQLQ grades of both groups were improved after one month treatment compared to the baseline, and the mean difference was significantly different between the two groups (P<0.05). Health related quality of life subscale such as exercise endurance, mentality status, reaction to stimulation and care to own health were significantly higher in the treatment group than in the control group. Traditional Uyghur medicine combined with western medicine showed similar effects in improving in ACT grades and AQLQ grades of asthma patients when compared to use of western medicine alone. However, use of traditional Uyghur medicine can improve health related quality of life of asthma patients when combined with western medicine, which was its advantage.